Doximity, Inc. reported mixed financial results for fiscal year 2026, showing a 5.1% revenue increase to $145.4 million but missing earnings per share estimates with a non-GAAP EPS of $0.26. The company is seeing rapid adoption of its AI-driven clinical tools and strong enterprise interest, yet monetization is hindered by regulatory and operational challenges. For fiscal year 2027, Doximity expects modest 4% revenue growth and further EBITDA margin compression as it invests heavily in AI, marking a transition year. The stock valuation now reflects a more mature SaaS business profile with increased risks around execution and growth transition.
Sodexo has secured a major global contract to provide catering services across more than 130 Meta sites in over 30 countries. This large-scale partnership includes diverse locations such as headquarters, campuses, data centers, and conference centers...
Allied Critical Metals announced positive assay results from its 2026 drilling campaign at the Santa Helena Breccia, part of the Borralha Tungsten Project in Portugal. The first drill hole confirmed broad zones of high-grade tungsten mineralization, ...
XRP surged about 4% to $1.11 following a broader crypto market rebound triggered by softer U.S. inflation data. Technical signals suggest a bullish inverse head and shoulders pattern, with potential for a 20% price increase if XRP breaks the $1.12–$1...
Revolut has received preliminary approval from Dubai's Virtual Assets Regulatory Authority to offer cryptocurrency services in the UAE, including broker-dealer, asset management, and exchange functions. This approval allows UAE customers to trade and...
Gold and silver prices are under pressure ahead of key U.S. retail sales data that could influence Federal Reserve interest rate decisions. Central banks, led by Poland and China, continue to boost gold reserves, adding 41 tonnes in May, supporting l...
